Financials HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
306.7 USD -2.37% Intraday chart for HCA Healthcare, Inc. +0.52% +13.30%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 50,134 55,649 79,908 67,841 72,450 81,119 - -
Enterprise Value (EV) 1 83,235 84,860 1,13,036 1,05,017 1,11,108 1,20,463 1,19,629 1,19,944
P/E ratio 14.7 x 15 x 12.1 x 12.5 x 14.3 x 14.9 x 13.4 x 12 x
Yield 1.1% 0.26% 0.75% 0.93% - 0.86% 0.91% 0.95%
Capitalization / Revenue 0.98 x 1.08 x 1.36 x 1.13 x 1.12 x 1.17 x 1.11 x 1.05 x
EV / Revenue 1.62 x 1.65 x 1.92 x 1.74 x 1.71 x 1.74 x 1.64 x 1.56 x
EV / EBITDA 8.44 x 8.45 x 8.94 x 8.7 x 8.73 x 9.06 x 8.53 x 8.09 x
EV / FCF 24.2 x 13.3 x 21 x 33.9 x 23.7 x 26.3 x 26.5 x 23.4 x
FCF Yield 4.14% 7.54% 4.76% 2.95% 4.22% 3.81% 3.77% 4.27%
Price to Book -18.3 x 98.8 x -90.5 x -25.6 x - -45.6 x -321 x 82.2 x
Nbr of stocks (in thousands) 3,39,178 3,38,375 3,11,023 2,82,717 2,67,661 2,64,499 - -
Reference price 2 147.8 164.5 256.9 240.0 270.7 306.7 306.7 306.7
Announcement Date 28/01/20 02/02/21 27/01/22 27/01/23 30/01/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 51,336 51,533 58,752 60,233 64,968 69,202 72,925 76,900
EBITDA 1 9,857 10,037 12,644 12,067 12,726 13,289 14,026 14,835
EBIT 1 7,261 7,316 9,791 9,098 9,649 10,027 10,648 11,250
Operating Margin 14.14% 14.2% 16.66% 15.1% 14.85% 14.49% 14.6% 14.63%
Earnings before Tax (EBT) 1 5,244 5,430 9,833 8,580 7,706 8,028 8,541 9,069
Net income 1 3,505 3,754 6,956 5,643 5,242 5,419 5,864 6,255
Net margin 6.83% 7.28% 11.84% 9.37% 8.07% 7.83% 8.04% 8.13%
EPS 2 10.07 10.93 21.16 19.15 18.97 20.58 22.92 25.55
Free Cash Flow 1 3,444 6,397 5,382 3,102 4,687 4,588 4,516 5,118
FCF margin 6.71% 12.41% 9.16% 5.15% 7.21% 6.63% 6.19% 6.66%
FCF Conversion (EBITDA) 34.94% 63.73% 42.57% 25.71% 36.83% 34.52% 32.2% 34.5%
FCF Conversion (Net income) 98.26% 170.4% 77.37% 54.97% 89.41% 84.66% 77.01% 81.83%
Dividend per Share 2 1.630 0.4300 1.920 2.240 - 2.640 2.793 2.903
Announcement Date 28/01/20 02/02/21 27/01/22 27/01/23 30/01/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 15,276 15,064 14,945 14,820 14,971 15,497 15,591 15,861 16,213 17,303 17,339 17,009 17,214 18,223 17,780
EBITDA 1 3,224 3,149 2,944 3,042 2,902 3,179 3,172 3,056 2,880 3,618 3,353 3,237 3,089 3,694 3,444
EBIT 1 2,508 2,421 2,212 2,304 2,153 2,429 2,416 2,293 2,111 2,829 2,558 2,438 2,278 2,861 2,612
Operating Margin 16.42% 16.07% 14.8% 15.55% 14.38% 15.67% 15.5% 14.46% 13.02% 16.35% 14.75% 14.33% 13.23% 15.7% 14.69%
Earnings before Tax (EBT) 1 3,157 2,586 1,814 1,760 1,704 3,302 1,922 1,809 1,630 2,345 2,247 1,922 1,781 2,353 2,098
Net income 1 2,269 1,814 1,273 1,155 1,134 2,081 1,363 1,193 1,079 1,607 1,591 1,291 1,188 1,580 1,468
Net margin 14.85% 12.04% 8.52% 7.79% 7.57% 13.43% 8.74% 7.52% 6.66% 9.29% 9.18% 7.59% 6.9% 8.67% 8.25%
EPS 2 7.000 5.750 4.140 3.900 3.910 7.280 4.850 4.290 3.910 5.930 5.930 4.870 4.520 6.144 5.706
Dividend per Share 2 0.4800 0.4800 0.5600 0.5600 0.5600 0.5600 0.6000 0.6000 0.6000 - 0.6568 0.6600 0.6600 0.6600 0.7121
Announcement Date 22/10/21 27/01/22 22/04/22 22/07/22 21/10/22 27/01/23 21/04/23 27/07/23 24/10/23 30/01/24 26/04/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 33,101 29,211 33,128 37,176 38,658 39,343 38,510 38,825
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.358 x 2.91 x 2.62 x 3.081 x 3.038 x 2.961 x 2.746 x 2.617 x
Free Cash Flow 1 3,444 6,397 5,382 3,102 4,687 4,588 4,516 5,118
ROE (net income / shareholders' equity) - - 352% - - 72.3% 54.1% 37.4%
ROA (Net income/ Total Assets) 8.32% 8.11% 14.2% 10.9% 9.46% 9% 10.4% 10.5%
Assets 1 42,127 46,274 49,116 51,590 55,400 60,208 56,141 59,360
Book Value Per Share 2 -8.060 1.660 -2.840 -9.390 - -6.720 -0.9600 3.730
Cash Flow per Share 2 21.80 26.90 27.30 28.90 34.10 35.40 36.60 39.80
Capex 1 4,158 2,835 3,577 4,395 4,744 5,152 5,286 5,555
Capex / Sales 8.1% 5.5% 6.09% 7.3% 7.3% 7.44% 7.25% 7.22%
Announcement Date 28/01/20 02/02/21 27/01/22 27/01/23 30/01/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
306.7 USD
Average target price
342.1 USD
Spread / Average Target
+11.53%
Consensus
  1. Stock Market
  2. Equities
  3. HCA Stock
  4. Financials HCA Healthcare, Inc.